![Lars Kåre Viksmoen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Kåre Viksmoen
Director/Board Member at PCI BIOTECH HOLDING ASA
Profile
Lars Kåre Viksmoen is currently an Independent Director at PCI Biotech Holding ASA and a Director at Labrida AS.
He previously served as President & Chief Executive Officer at GN Hearing A from 2012 to 2014, Chief Executive Officer at ArcticZymes Technologies ASA from 2006 to 2010, and Vice President & Regional Director-Europe at Merck & Co., Inc. in 2006.
He also served as an Independent Director at Veloxis Pharmaceuticals A and as Managing Director at MSD (Norge) AS in 1992.
Additionally, he was a Member-Executive Management at GN Store Nord A from 2012 to 2014.
Dr. Viksmoen holds a doctorate degree from the University of Oslo, which he received in 1974.
Lars Kåre Viksmoen active positions
| Companies | Position | Start |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Director/Board Member | 2016-04-30 |
Labrida AS
 Labrida AS Medical SpecialtiesHealth Technology Labrida AS provides novel device for maintenance of dental implants. The company was founded by Johan C. Wohlfahrt and Staale Petter Lyngstadaas in August 2012 and is headquartered in Oslo, Norway. | Director/Board Member | - |
Former positions of Lars Kåre Viksmoen
| Companies | Position | End |
|---|---|---|
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Chief Executive Officer | 2014-07-31 |
| GN STORE NORD A/S | Corporate Officer/Principal | 2014-07-31 |
| ARCTICZYMES TECHNOLOGIES ASA | President | 2010-02-28 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2006-08-31 |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology MSD (Norge) AS operates as research-based company that researches and develops new drugs. It offers pharmaceutical products, medical equipment, technical products, and other healthcare products and substances. The company is headquartered in Drammen, Norway. | President | 1991-12-31 |
Training of Lars Kåre Viksmoen
| University of Oslo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| GN STORE NORD A/S | Electronic Technology |
| MERCK & CO., INC. | Health Technology |
| PCI BIOTECH HOLDING ASA | Health Technology |
| Private companies | 4 |
|---|---|
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Health Technology |
MSD (Norge) AS
MSD (Norge) AS Pharmaceuticals: MajorHealth Technology MSD (Norge) AS operates as research-based company that researches and develops new drugs. It offers pharmaceutical products, medical equipment, technical products, and other healthcare products and substances. The company is headquartered in Drammen, Norway. | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Labrida AS
Labrida AS Medical SpecialtiesHealth Technology Labrida AS provides novel device for maintenance of dental implants. The company was founded by Johan C. Wohlfahrt and Staale Petter Lyngstadaas in August 2012 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Lars Kåre Viksmoen
